#United States #New York #Securities Act #BYAH #Park Ha Bio

BYAH Investors Given a Critical Deadline for Class Action Claims

A significant announcement has been made regarding the ongoing challenges faced by Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH). The firm SueWallSt has declared that a class action lawsuit concerning securities has been lodged against the company, enabling those affected by its alleged actions from December 27, 2024, through July 8, 2025, to potentially seek recovery. Investors who incurred losses during this timeframe must be aware of the approaching deadline to participate in this class action. The cut-off date is set for September 28, 2026.

Overview of the Allegations

The core of the allegations revolves around the company not disclosing essential information in its December 2024 registration statement about a concerning structure related to its public shares. This issue led to an extraordinarily high volatility in share prices, culminating in a staggering 93% collapse in the stock price within a single session. Shareholders who experienced financial losses as a result of this situation may have legal grounds to pursue recovery.

On the IPO date, BYAH shares hit the market at $4.00, raising approximately $4.8 million for the firm. Notably, shares achieved an unprecedented high of $41.49 in July 2025, only to plummet to $2.99 the next day. The dramatic decline removed over $1 billion in market capitalization, demonstrating the gravity of the situation for shareholders.

Details About the Class Action Suit

The lawsuit, currently pending before the United States District Court for the Southern District of New York, describes several serious misrepresentations and omissions in the initial registration statement, including:

• - Low Public Float: Only a minimal fraction of total shares (1,200,000 out of 26,200,000) were made available for public trading, representing less than 5% of the total shares. This low float has been argued to have created conditions ripe for price manipulation.
• - Insider Control: It has been reported that insiders retained a tremendous portion of the shares (over 95%), which effectively concentrated controlling voting power within a few entities.
• - Misleading Risk Factors: The risks associated with IPOs with such minimal float were downplayed, leading investors to believe that skyrocketing stock prices were merely a part of market theory instead of a present reality.
• - Omission of Fraudulent Practices: Prominent promotional activities that allegedly took place on social media and other platforms were not adequately disclosed, leading to speculative trading that was not substantiated by the company's operating realities.

The claims asserted in this class action fall under the purview of the Securities Act of 1933, including sections 11, 12, and 15, as well as sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

Legal Representation and Next Steps

Investors who believe they might qualify for recovery are highly encouraged to reach out to legal representatives. Joseph E. Levi, Esq. can be contacted at [email protected] or by calling (888) SueWallSt for guidance through this process. In addition, they should prepare documentation, including brokerage statements, to validate their financial losses.

This lawsuit will aim to hold defendants accountable for their actions and help investors recover losses incurred as a result of alleged securities fraud. Investors are urged to note the crucial deadline on September 28, 2026, to file for lead plaintiff roles. Overall, the class action offers a lifeline to those left vulnerable by what could be regarded as a manipulation scheme in the trading of BYAH shares.

Stay informed about your rights as an investor and do not hesitate to seek the legal recourse available for potential recovery. The coming months will prove essential for the BYAH investor community as they navigate through these legal proceedings.

Conclusion

As the deadline approaches, time is of the essence for affected investors to secure their participation in the class action suit against Park Ha Biological Technology Co., Ltd. Thorough expertise from seasoned securities litigation professionals could help shed light on potential paths for recovering losses incurred during this turbulent period. Act now and take control of your investment future by making informed choices.